Medical education on hospital hyperglycemia improving knowledge and outcomes

ABSTRACT Objective: To evaluate the effects of medical education on hospital hyperglycemia on physician's technical knowledge and the quality of medical prescriptions, patient care, and clinical outcomes. Subjects and methods: The intervention included online classes and practical consultations provided by an endocrinologist to medical preceptors and residents of the Department of Internal Medicine. A pretest and a post-test (0 to 10 points) were applied before and after the intervention and patients medical records were reviewed before and after the intervention. The outcomes were improvement in medical knowledge, in the quality of prescriptions for patients in the clinical area, and clinical outcomes. Results: The global mean of correct answers improved with the intervention [before: 6.9 points (±1.7) versus after the intervention: 8.8 points (±1.5) (p < 0.001)]. The number of patients who did not have at least one blood glucose assessment during the entire hospitalization for acute illness decreased from 12.6% before to 2.6% (p < 0.001) after the intervention. There was also a significant reduction in hospital hypoglycemia rates (p < 0.026). The use of sliding-scale insulin as the main treatment was quite low before and after the intervention (2.2% and 0%). After 6 months, medical knowledge did not show significant reduction. Conclusion: Medical education on hospital hyperglycemia can improve medical knowledge and clinical outcomes for patients. The improvement in medical knowledge was maintained after 6 months.

The effectiveness of insulin therapy in the functional and morphological recovery of leydig cells in rats submitted to Diabetes mellitus

The effects of systemic insulin administration at different concentrations on the testicular tissue of diabetic adult rats, induced by streptozotocin, are evaluated by the morphological analysis of spermatogenic process. Twenty-four adult male rats were divided into 1) Control Group: they received citrate buffer, by intraperitoneal injection; 2) Diabetic Group: induced by intraperitoneal injection of streptozotocin (60 mg. kg-1 of body weight); 3) Insulin 50%: induced diabetes treated with half of standard dosage of insulin; 4) Insulin 100%: induced diabetes treated with standard dose of insulin. After eight weeks, animals were weighted and anesthetized; testicles were removed and processed in resin. Body and testicular weight of diabetic rats decreased when compared to that of control. Parameters increased with insulin therapy. Testosterone levels were low in diabetic animals but rates recovered after insulin therapy. Nuclear diameter and volume of Leydig cells decreased in diabetic rats although they significantly increased after insulin therapy. Results showed that the administration of insulin in diabetic rats promoted a protective effect of testicular parenchyma, enhancing efficient recovery on testosterone levels and increase in daily sperm production.

Fatores que predispõem o uso inadequado de insulinas em diabéticos em uma unidade de saúde no município de Jaguaruana-Ceará / Factors that predispose to the inappropriate use of insulin in diabetics in a health unit in the city of Jaguaruana- Ceará / Factores que predisponen al uso inadecuado de insulina en diabéticos de una unidad de salud de la ciudad de Jaguaruana-Ceará

Introdução: O diabetes mellitus é um distúrbio metabólico crônico que afeta grande parcela da população mundial, no Brasil o número de diabéticos vem crescendo significativamente com o passar dos anos. A qualidade de vida destes pacientes está intimamente relacionada ao tratamento adequado que pode reduzir as complicações decorrentes da doença. O estudo teve como objetivo identificar dificuldades no uso de insulinas em pacientes da unidade de saúde do município de Jaguaruana-CE que possam estar relacionados a falhas no tratamento. Métodos: Tratou-se de uma análise do tipo descritivo, transversal e observacional com uma abordagem quantitativa, o questionário foi aplicado aos pacientes no momento da consulta na Unidade Básica de Saúde (UBS). A pesquisa ocorreu entre os meses de setembro a outubro de 2022 com mulheres e homens insulinodependentes acima de 18 anos. Resultados: Os dados mostraram maior prevalência de mulheres, 20 (67%), a maior faixa etária foi acima de 40 anos, 19 (63%) e a renda familiar prevaleceu de 1 à 2 salários mínimos, 14 (47%). O profissional de prestou maior orientação quanto ao uso da insulina foi o enfermeiro, citado por 12 (40%) pacientes, 20 (67%) relataram armazenar a insulina na porta da geladeira, 22 (74%) relataram desconhecer o motivo das aplicações dolorosas e 9 (30%) confirmam perder ou pular uma das aplicações diárias. Conclusão: Nota-se, portanto, a necessidade da atuação do farmacêutico na saúde da família, na avaliação e orientação quanto ao uso correto das insulinas, garantindo assim o uso racional e com maior eficácia.

Introduction: Diabetes mellitus is a chronic metabolic disorder that affects a large portion of the world population. In Brazil, the number of diabetics has been growing significantly over the years. The quality of life of these patients is closely related to adequate treatment that can reduce the complications arising from the disease. This study aimed to identify difficulties in the use of insulin in patients at the health care facility in the city of Jaguaruana-CE that may be related to treatment failure. Methods: This was a descriptive, cross-sectional and observational analysis with a quantitative approach, the questionnaire was applied to patients at the time of consultation in the Basic Health Unit (BHU). The research occurred between the months of September to October 2022 with insulin-dependent women and men over 18 years. Results: The data showed higher prevalence of women, 20 (67%), the highest age group was above 40 years, 19 (63%) and family income prevailed from 1 to 2 minimum wages, 14 (47%). The professional who provided the most orientation regarding insulin use was the nurse, mentioned by 12 (40%) patients, 20 (67%) reported storing insulin in the refrigerator door, 22 (74%) reported not knowing the reason for the painful applications, and 9 (30%) confirmed missing or skipping one of the daily applications. Conclusion: Therefore, it is noted the need for the role of the pharmacist in family health, in the evaluation and guidance on the correct use of insulin, thus ensuring the rational use and with greater efficacy.

Introducción: La diabetes mellitus es un trastorno metabólico crónico que afecta a gran parte de la población mundial, en Brasil el número de diabéticos viene creciendo significativamente a lo largo de los años. A qualidade de vida destes pacientes está estreitamente relacionada com um tratamento adequado que permita reduzir as complicações decorrentes da doença. O estudo teve como objetivo identificar dificuldades no uso de insulinas em pacientes da unidade de saúde do município de Jaguaruana-CE que possam estar relacionadas a falhas no tratamento. Método: Se trató de un análisis descriptivo, transversal y observacional con abordaje cuantitativo, el cuestionario fue aplicado a los pacientes en el momento de la consulta en la Unidad Básica de Salud (UBS). La investigación ocurrió entre los meses de septiembre a octubre de 2022 con mujeres y hombres insulinodependientes mayores de 18 años. Resultados: Los datos mostraron mayor prevalencia de mujeres, 20 (67%), el grupo de mayor edad fue superior a 40 años, 19 (63%) y la renta familiar prevaleció de 1 a 2 salarios mínimos, 14 (47%). El profesional que más orientó sobre el uso de la insulina fue la enfermera, mencionada por 12 (40%) pacientes, 20 (67%) relataron haber guardado la insulina en la puerta del refrigerador, 22 (74%) relataron no saber el motivo de las aplicaciones dolorosas y 9 (30%) confirmaron haber omitido o saltado una de las aplicaciones diarias. Conclusión: Se constata, por lo tanto, la necesidad del papel del farmacéutico en la salud familiar, en la evaluación y orientación en cuanto al uso correcto de las insulinas, garantizando así el uso racional y con mayor eficacia.

Motivating Persons Living with Diabetes for Insulin/Injectable Therapy

Motivating patients to initiate or intensify insulin is a challenging aspect of diabetes practice. This paper reviews certain motivational strategies and methods used for insulin initiation/intensification. It places various domains of motivational interviewing in perspective, under a single umbrella, making it easier for practitioners to understand the art and science of insulin motivation.

Fundamentos que caracteriza la adherencia a la insulinoterapia de los pacientes con diabetes tipo II / Foundations that characterize adherence to the insulin therapy of patients with type II diabetes

La diabetes Mellitus es un padecimiento que empieza cuando el páncreas no realiza un uso adecuado de la insulina que produce o no puede lograr producir insulina. Se descomponen en glucosa en la sangre todos los alimentos ricos en hidratos de carbono; la insulina da ayuda a la glucosa para que esta pueda ingresar en las células. Los niveles de azúcar en la sangre al no funcionar bien el páncreas suben, lo cual debe ser controlado por medio de un tratamiento médico de por vida, y lo más importante la persona debe cambiar de hábitos en su salud. Objetivo: El objetivo principal de esta investigación es definir el efecto que produce la adherencia a la insulinoterapia en los pacientes con diabetes tipo II del Hospital del Día Mariana de Jesús. Materiales y Métodos: Se utilizó una investigación cuantitativa, transversal ya que se realizó una encuesta a los pacientes, la cual se procedió a la recolección y análisis e interpretación de datos. La muestra trabajada fue de 100 pacientes, los cuales fueron atendidos en el Hospital por concepto de diabetes tipo II en el área de emergencia. Resultados: Como resultado de la investigación tenemos que el 76% de los encuestados conocen sobre el tratamiento de la insulinoterapia, el 85% se rehusó a utilizar insulina cuando inició su tratamiento, el 75% ha tenido dificultad para la conservación de la insulina, el 63% considera que el uso de la insulina es riesgos, el 53% indicó haber recibido asesoría sobre los posibles efectos de la insulina, al 65% de encuestados su jornada laboral no le permite asistir a su control médico, el 72% ha sentido un desmejoro en su salud al dejar el tratamiento y el 63% de los encuestados indicó que ha abandonado en algún momento su tratamiento por temor a los efectos secundarios que dicen tener. Conclusiones: Se estableció el tipo de complicaciones que se dan en los pacientes ante la no adherencia a la insulinoterapia, uno de ellos fue, que al dejar el tratamiento los pacientes sintieron un desmejoro en su estado de salud, así también, los pacientes han abandonado el tratamiento en algún momento por miedo a los efectos secundarios que dicen tener la insulina(AU)

Diabetes Mellitus is a condition that begins when the pancreas does not make proper use of the insulin it produces or cannot achieve produce insulin. All foods rich in glucose are broken down into glucose in the blood. carbohydrates; insulin helps glucose to enter the cells cells. When the pancreas does not work well, blood sugar levels rise, which must be controlled by lifelong medical treatment, and most importantly the person must change their health habits. Objective: The main objective of this research is to define the effect produced by adherence to insulin therapy in patients with type II diabetes at Hospital del Día Mariana de Jesús. Materials and Methods: A quantitative, cross-sectional investigation was used since a patient survey which proceeded to the collection and analysis and interpretation of data. The sample worked was 100 patients who were treated at the Hospital for type II diabetes concept in the emergency area. Results: Like result of the investigation we have that 76% of the respondents know about the insulin therapy treatment, 85% refused to use insulin when they started their treatment, 75% have had difficulty conserving insulin, 63% considers that the use of insulin is risky, 53% indicated having received counseling about the possible effects of insulin, 65% of those surveyed did not care about their working hours. allows them to attend their medical control, 72% have felt a deterioration in their health when leaving the treatment and 63% of those surveyed indicated that they had abandoned their treatment at some point. treatment for fear of the side effects they claim to have. Conclusions: If established the type of complications that occur in patients due to non-adherence to insulin therapy, one of them was that when leaving the treatment the patients felt a deterioration in their state of health, as well as the patients have abandoned the treatment at some point for fear of the side effects that they claim to have insulin(AU)

Tratamento para o diabetes mellitus gestacional: uma revisão de literatura / Treatment for gestational diabetes mellitus: a literature review

O diabetes mellitus gestacional (DMG) é uma complicação que atinge o metabolismo da gestante, resultando em intolerância à glicose e consequente hiperglicemia, originada pela insuficiência de insulina materna. Este estudo tem como objetivo identificar os tratamentos disponíveis e mais utilizados para o DMG. Trata-se de um uma revisão de literatura, feita a partir de 22 referências, acerca dos tratamentos para o DMG. As bases de dados escolhidas foram Google Acadêmico, UpToDate, SciELO e o acervo da Universidade do Planalto Catarinense. Estudos apontam a insulina humana ­ NPH e regular ­ como a principal escolha, quando comparada aos seus análogos, apesar de ainda existirem muitas controvérsias quanto ao início do tratamento, o esquema terapêutico e os ajustes das doses. Pesquisas têm demonstrado bons resultados sobre a eficácia e a segurança dos hipoglicemiantes orais ­ gliburida e metformina ­ no tratamento de gestantes diabéticas, mas é evidente a necessidade de mais estudos para confirmar a efetividade deles e garantir um bom desenvolvimento do concepto. Concluiu-se que o controle dietético e o exercício físico são a primeira opção de tratamento para o DMG. Todavia, caso a euglicemia não seja atingida, opta-se pelo tratamento medicamentoso por meio da insulinoterapia ou hipoglicemiantes orais, o que possibilita a redução da incidência dos efeitos adversos ao binômio materno-fetal.(AU)

Gestational diabetes mellitus (DMG) is a complication that affects the pregnant woman's metabolism, resulting in glucose intolerance and consequent hyperglycemia, caused by insufficient maternal insulin. This study aims to identify the available and most used treatments for DMG. This is a literature review, based on 22 references, about treatments for Gestational Diabetes; the databases chosen were Google Scholar, UpToDate, SciELO and the collection of the Universidade do Planalto Catarinense. Studies point to human insulin ­ NPH and regular ­ as the main choice when compared to its analogues, although there are still many controversies about the beginning of treatment, therapeutic scheme and dose adjustments. Researches have shown good results on the efficacy and safety of oral hypoglycemic agents ­ glyburide and metformin ­ in the treatment of diabetic pregnant women, but it is evident the need for further studies to confirm their effectiveness and to guarantee a good development of the fetus. It was concluded that dietary control and physical exercise are the first treatment option for DGM. However, if euglycemia is not achieved, drug treatment is chosen through insulin therapy or oral hypoglycemic agents, which makes it possible to reduce the incidence of adverse effects to the maternal-fetal binomial.(AU)

Monitoreo continuo de glucosa: indicaciones, interpretación de datos y toma de decisiones terapéuticas. Recomendaciones de expertos / Continuous glucose monitoring: indications, data interpretation and making therapeutic decisions. Expert recommendations

Las herramientas para evaluar el grado de control glucémico se modificaron últimamente. La emoglobina glicosilada (HbA1c), parámetro de referencia (gold standard), refleja el control glucémico de los últimos tres meses de manera retrospectiva, sin expresar la variabilidad glucémica. El automonitoreo glucémico capilar (AGC) brinda información inmediata y prospectiva, pero dispone de pocos datos glucémicos para generar promedios y desviaciones estándares representativas. No detecta tendencias y tiene limitaciones para obtener datos nocturnos o durante la actividad física. Es invasivo y muchas veces rechazado. Contrariamente, el monitoreo continuo de glucosa (MCG) mide la glucosa instantáneamente, y muestra sus tendencias y su variabilidad en forma continua, incorporando nuevas métricas de control. Mediante el perfil ambulatorio de glucosa (PAG) se analizan los patrones del control glucémico durante el sueño, los ayunos prolongados, la actividad física y las intercurrencias, expresándolos como curvas con sus desviaciones estándar durante períodos de horas (8 a 24 horas) o días (7, 14, 30 y 90 días). El PAG contiene las siguientes métricas: porcentaje de tiempo en rango TIR (del inglés, time in range), porcentaje de tiempo por encima del rango TAR (del inglés, time above range), porcentaje de tiempo por debajo del rango o hipoglucemia TBR (del inglés, time below range) y coeficiente de variabilidad (%CV). La información continua permite tomar decisiones inmediatas, ya sea con la ingesta de carbohidratos o con la aplicación de insulina. El MCG con terapéuticas insulínicas inyectables (TII) o bomba portable de insulina (BPI) es una herramienta muy útil y complementaria para el tratamiento de la diabetes mellitus tipo 1 (DM1) y la DM2 en la insulinoterapia. Su utilización se asoció con descensos significativos en la HbA1c, disminución de la variabilidad glucémica, reducción de las hipoglucemias totales y nocturnas, y mejoría de la calidad de vida en estos pacientes. Nuestro propósito como grupo de expertos es generar una guía práctica para regular la implementación del MCG.

The tools to assess the degree of glycemic control were modified lately. Glycosylated hemoglobin (HbA1c), the gold standard, reflects the glycemic control of the last 3 months retrospectively, without expressing glycemic variability. Selfblood glucose monitoring (SBGM) provides immediate and prospective information, but has little glycemic data to generate representative averages and standard deviations. It does not detect trends and has limitations to obtain nocturnal data or during physical activity. It is invasive and often rejected. On the contrary, continuous glucose monitoring (CGM), allows to measure glucose instantly, shows your trends and variability continuously, incorporating new control metrics. The ambulatory glucose profile (AGP) analyzes the patterns of glycemic control during sleep, prolonged fasting, physical activity and intercurrences, expressing them as curves with their standard deviations during periods of hours (8 to 24 hours) or days (7, 14, 30 and 90 days). The AGP contains the following metrics: percentage time in range (TIR), percentage time above range mg/dl (TAR), percentage time below range or hypoglycemia (TBR) and coefficient of variation (%CV). CGM with IIT or continuous subcutaneous insulin infusion (CSII), is a very useful and complementary tool for the treatment of DM1 and DM2 in insulin therapy. Its use was associated with significant decreases in HbA1c, decreased glycemic variability, reduction of total and nocturnal hypoglycemia and improvement of the quality of life in these patients. Our aim as a group of experts is to generate a practical guide to regulate the implementation of the CGM.

Beliefs related to insulin use in people with Type 2 Diabetes Mellitus / Creencias relacionadas con el uso de insulina en personas con Diabetes Mellitus tipo 2 / Crenças relacionadas ao uso de insulina em pessoas com Diabetes Mellitus tipo 2

ABSTRACT Objectives: to identify the beliefs of people with Type 2 Diabetes Mellitus related to insulin use. Methods: a descriptive, cross-sectional, quantitative-qualitative study based on Theory of Planned Behavior and performed with 32 participants using insulin. The data were analyzed and grouped into categories by beliefs similarity, counted from the frequencies. Results: 118 behavioral, 60 normative and 97 control beliefs were issued. Among the behavioral beliefs, there was an advantage in keeping the diabetes under control and disadvantage, the pain of being pierced by the application of insulin. Regulations highlighted the children as referents who support the treatment. In control beliefs, it was observed that the application of insulin appears as easiness and difficulty to the treatment. Conclusions: the study will support the construction of a psychometric scale to measure the determinants of insulin use, revealing particularities for the structuring of educational interventions that contribute to adherence of the treatment verified in adequate glycemic control.

RESUMEN Objetivos: identificar las creencias de personas con Diabetes Mellitus tipo 2, relacionadas con el uso de insulina. Métodos: el estudio descriptivo, transversal y cuantitativo, fundamentado en la Theory of Planned Behavior y realizado con 32 participantes en uso de insulina. Los datos fueron analizados y agrupados en categorías por la similitud de las creencias, contabilizados a partir de las frecuencias. Resultados: se emitieron 118 creencias comportamentales, 60 normativas y 97 de control. Entre las creencias comportamentales, se destacó la ventaja en mantener la diabetes controlada y desventaja, dolor de la perforación por la aplicación de insulina. Las normativas destacaron a los hijos como referentes que apoyan el tratamiento. En las creencias de control, se observó que la aplicación de la insulina aparece como facilidad y dificultad al tratamiento. Conclusiones: el estudio subsidiará la construcción de escala psicométrica para medir los factores determinantes del uso de la insulina, desvelando particularidades para la estructuración de intervenciones educativas que contribuyan con adhesión del tratamiento verificado en el control glucémico adecuado.

RESUMO Objetivos: identificar as crenças de pessoas com Diabetes Mellitus tipo 2, relacionadas ao uso de insulina. Métodos: estudo descritivo, transversal e quanti-qualitativo, fundamentado na Theory of Planned Behavior e realizado com 32 participantes em uso de insulina. Os dados foram analisados e agrupados em categorias pela similitude das crenças, contabilizados a partir das frequências. Resultados: foram emitidas 118 crenças comportamentais, 60 normativas e 97 de controle. Entre as crenças comportamentais, destacou-se vantagem em manter o diabetes controlado e desvantagem, dor da furada pela aplicação de insulina. As normativas destacaram os filhos como referentes que apoiam o tratamento. Nas crenças de controle, observou-se que a aplicação da insulina aparece como facilidade e dificuldade ao tratamento. Conclusões: o estudo subsidiará a construção de escala psicométrica para mensurar os fatores determinantes do uso da insulina, desvendando particularidades para estruturação de intervenções educativas que contribuam com adesão do tratamento verificado no controle glicêmico adequado.

Perfil epidemiológico de gestantes diabéticas no município de Itajaí/SC / Epidemiological profile of diabetic pregnancies at Itajaí city SC

A diabetes mellitus gestacional (DMG) consiste em qualquer intolerância à glicose com início durante a gestação. É a desordem metabólica mais comum da gravidez, atingindo entre 3 a 25% das gestações, sendo que 90% das gestantes apresentam um ou mais fatores de risco para a doença. O estudo teve por finalidade descrever o perfil clínico-epidemiológico das gestantes portadoras de diabetes mellitus gestacional com parto no ano de 2016 atendidas no serviço de alto risco no município de Itajaí (SC), bem como os fatores de risco e desfechos gestacionais associados à doença. Tratou-se de uma análise retrospectiva, descritiva, quantitativa e transversal, com a coleta de dados dos prontuários. De 328 parturientes atendidas no serviço, 54 (16,46%) preencheram os critérios de inclusão (data do parto entre 01 de janeiro a 31 de dezembro de 2016 e que possuíam prontuário na unidade). Entre essas pacientes, a maioria era de etnia branca (55,55%) com idade entre 31 e 35 anos (29,62%) e ensino médio completo (29,62%). Obesidade prévia foi descrita em 64,81%. A idade gestacional média de diagnóstico foi de 26,44 semanas. O tratamento com insulinoterapia foi instituído em 25,92%. Houve relato de doença hipertensiva da gravidez em 16,66%. A taxa de cesariana foi de 59,2%; a prevalência de recém-nascidos grandes para a idade gestacional foi de 12,96%; sendo que 5,5% de neonatos foram admitidos em unidade de terapia intensiva. Constatou-se que a maioria das gestantes teve um pré-natal adequado e sem intercorrências e que em alguns casos houve encaminhamento tardio ao serviço especializado.

Gestational Diabetes Mellitus (GDM) consists of any glucose intolerance beginning during pregnancy. It's pregnancy's most common metabolic disorder reaching 3 to 25% of pregnancies, and 90% of pregnant women present one or more risk factors for the disease. The purpose of this study was to describe the clinical-epidemiological profile of pregnant women forwarded to the reference center diagnosed with gestational diabetes mellitus and who delivered in 2016 at Itajaí city, SC, as well as the risk factors and gestational outcomes associated with the disease. It was a retrospective, descriptive, quantitative and cross-sectional analysis, with data collected from patients records. Of the 328 parturients attended in the service, 54 (16.46%) met the inclusion criteria (date of delivery between January 1 and December 31, 2016, and that they had medical records in the unit). Among these patients, the majority were white (55.55%) aged 31-35 years (29.62%) and with complete secondary education (29.62%). Previous obesity was described in 64.81%. The average gestational age at diagnosis of gestational diabetes was 26.44 weeks. The treatment with insulin therapy was instituted in 25.92%. There were reports of hypertension in pregnancy in 16.66%. The cesarean rate was 59.2%; the prevalence of large newborns for gestational age was 12.96%; and 5.5% of newborns were admitted in intensive care unit. It was found that most of the pregnant women had an adequate prenatal and without intercurrences and that in some cases delayed referral to the specialized service.

Terapia complementaria a la insulina en el tratamiento de niños y adolescentes con diabetes mellitus tipo 1- (DM1) / Therapies complementaries to insulin in the treatment of children and adolescents with type 1 diabetes mellitus (T1DM)

La diabetes mellitus tipo 1 (DM1), es una enfermedad crónica caracterizada por la deficiencia de insulina debido a la pérdida de células ß pancreáticas, las alteraciones hormonales en la DM 1 no se limitan a la deficiencia de insulina; existiendo también secreción inadecuadada de glucagón en el período postprandial. Aunque el control glucémico con terapias intensivas con insulina ha reducido la incidencia de complicaciones microvascular y macrovasculares. La mayoría de las personas con DM1 tienen un control glucémico subóptimo; Por lo tanto, el uso de farmacoterapia adyuvante para mejorar el control ha sido de interés clínico. El uso de estos nuevos medicamentos brindaría la oportunidad de imitar más de cerca la fisiología pancreática normal, y contrarrestar otros mecanismos fisiopatológicos diferentes a Insulinopenia; contribuyendo a lograr un mejor control metabólico y expectativa de vida.

Type 1 diabetes mellitus (T1DM), is a chronic disease characterized by insulin deficiency due to the loss of pancreatic ß cells, the hormonal alterations in T1DM are not limited to insulin deficiency; there is also a deregulated glucagon secretion in the postprandial period. Although glycemic control with intensive therapies with insulin has reduced the incidence of microvascular and macrovascular complications, most people with T1DM1 glycemic control; therefore, the use of adjuvant pharmacotherapy to improve control has been of clinical interest. The use of these new drugs would offer the opportunity to imitate more closely the normal pancreatic physiology, and to counteract other physiopathological mechanisms different from insulinopenia; contributing to achieve better metabolic control and life expectancy.

Effect of intensive insulin therapy on immune function and prognosis in severe chest trauma patients with stress hyperglycemia / 中华创伤杂志

Objective@#To investigate the effect of intensive insulin therapy on the immune function and prognosis of severe thoracic injuries patients with stress hyperglycemia.@*Methods@#A retrospective case control study was performed to analyze the clinical data of 60 patients with severe chest trauma and stress-induced hyperglycemia admitted to Chongqing People's Hospital from October 2016 to October 2018. There were 31 males and 26 females, aged 25-61 years [(46.1±4.0)years]. The abbreviated injury scale (AIS) range was 3-5 points. Thirty patients received routine insulin therapy (routine treatment group) and thirty patients received intensive insulin therapy (intensive treatment group). Venous blood was collected from two groups of patients before treatment, 1 day, 3 days, 5 days and 7 days after treatment respectively. Level of inflammatory cytokines [tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and C-reactive protein (CRP)], and lymphocyte count (CD14＋, CD4＋ and CD4＋/CD8＋) were detected respectively. The incidence of nosocomial infection, length of hospital stay, mortality and incidence of hypoglycemia were compared between the two groups.@*Results@#There were no significant differences in plasma TNF-α, IL-6 and CRP levels between the two groups before treatment (P>0.05). After treatment (1-7 days), the levels of serum TNF-α, IL-6 and CRP in the intensive treatment group were lower than those of routine treatment group (P<0.05 or 0.01). Compared with these before treatment, the levels of TNF-α, IL-6 and CRP in both groups increased to varied degrees, reaching a peak on day 3, followed by a gradual decline (P<0.05 or 0.01). There were no statistically significant differences in CD14＋, CD4＋、CD4＋/CD8＋ lymphocyte counts between the two groups before treatment (P>0.05). On days 3, 5, and 7 after treatment, the counts of CD14＋ lymphocytes [3 d: (0.61±0.08)×109 vs. (0.55±0.09)×109, 5 d: (0.68±0.05)×109 vs. (0.63±0.05)×109, 7 d: (0.77±0.07)×109 vs. (0.71±0.06)×109], CD4＋ lymphocytes [3 d: (0.29±0.04)×109 vs. (0.25±0.03)×109, 5 d: (0.32±0.04)×109 vs. (0.30±0.05)×109, 7 d: (0.34±0.03)×109 vs. (0.32±0.06)×109], CD4＋/CD8＋ lymphocytes [3 d: (0.28±0.04)×109 vs. (0.26±0.06)×109, 5 d: (0.33±0.03)×109 vs. (0.31±0.06)×109, 7 d: (0.35±0.03)×109 vs. (0.32±0.06)×109] in the intensive treatment group were higher than those in the routine treatment group. Compared with before treatment, the counts of CD14+ , CD4+ , CD4+ /CD8+ lymphocytes in the two groups were raised to different degrees after treatment for 3 days, with significant differences (P<0.05 or 0.01). Compared with routine treatment group, patients in intensive treatment group had lower incidence of nosocomial infection [57%(17/30) vs. 30%(9/30)], shorter duration of mechanical ventilation [(12.8±2.4)vs. (7.4±1.2)days], and lower hospital mortality rate [27%(8/30) vs. 10%(3/30)]. There was no significant difference in the incidence of hypoglycemia between the two groups(P>0.05).@*Conclusion@#For severe chest trauma patients with stress hyperglycemia, intensive insulin therapy can effectively improve the immunity, inhibit the inflammatory reaction, reduce the complication incidence, restore ventilation function and improve survival rate.

Effect of intensive insulin therapy on immune function and prognosis in severe chest trauma patients with stress hyperglycemia / 中华创伤杂志

Objective To investigate the effect of intensive insulin therapy on the immune function and prognosis of severe thoracic injuries patients with stress hyperglycemia.Methods A retrospective case control study was performed to analyze the clinical data of 60 patients with severe chest trauma and stress-induced hyperglycemia admitted to Chongqing People's Hospital from October 2016 to October 2018.There were 31 males and 26 females,aged 25-61 years [(46.1 ± 4.0)years].The abbreviated injury scale (AIS) range was 3-5 points.Thirty patients received routine insulin therapy (routine treatment group) and thirty patients received intensive insulin therapy (intensive treatment group).Venous blood was collected from two groups of patients before treatment,1 day,3 days,5 days and 7 days after treatment respectively.Level of inflammatory cytokines [tumor necrosis factor-α (TNF-α),interleukin-6 (IL-6) and C-reactive protein (CRP)],and lymphocyte count (CD14 +,CD4 +and CD4 +/CD8 +) were detected respectively.The incidence of nosocomial infection,length of hospital stay,mortality and incidence of hypoglycemia were compared between the two groups.Results There were no significant differences in plasma TNF-α,IL-6 and CRP levels between the two groups before treatment (P ＞ 0.05).After treatment (1-7 days),the levels of serum TNF-α,IL-6 and CRP in the intensive treatment group were lower than those of routine treatment group (P ＜ 0.05 or 0.01).Compared with these before treatment,the levels of TNF-α,IL-6 and CRP in both groups increased to varied degrees,reaching a peak on day 3,followed by a gradual decline (P ＜ 0.05 or 0.01).There were no statistically significant differences in CD14 +,CD4 + 、CD4 +/CD8 + lymphocyte counts between the two groups before treatment (P ＞ 0.05).On days 3,5,and 7 after treatment,the counts of CD14+ lymphocytes [3 d:(0.61 ±0.08) × 109 vs.(0.55 ±0.09) × 109,5 d:(0.68 ±0.05) × 109 vs.(0.63±0.05) ×109,7 d:(0.77±0.07) ×109 vs.(0.71±0.06) ×109],CD4 + lymphocytes [3 d:(0.29 ±0.04) × 109 vs.(0.25 ±0.03) × 109,5 d:(0.32 ±0.04) × 109 vs.(0.30 ±0.05) × 109,7 d:(0.34±0.03) ×109 vs.(0.32±0.06) ×109],CD4 +/CD8+ lymphocytes [3 d:(0.28 ±0.04) ×109 vs.(0.26 ±0.06) × 109,5 d:(0.33 ±0.03) × 109 vs.(0.31 ±0.06) × 109,7 d:(0.35 ±0.03) × 109 vs.(0.32 ± 0.06) × 109] in the intensive treatment group were higher than those in the routine treatment group.Compared with before treatment,the counts of CD14 +,CD4 +,CD4 +/CD8 + lymphocytes in the two groups were raised to different degrees after treatment for 3 days,with significant differences (P ＜0.05 or 0.01).Compared with routine treatment group,patients in intensive treatment group had lower incidence of nosocomial infection [57％ (17/30) vs.30％ (9/30)],shorter duration of mechanical ventilation [(12.8 ± 2.4) vs.(7.4 ± 1.2) days],and lower hospital mortality rate [27％ (8/30) vs.10％ (3/30)].There was no significant difference in the incidence of hypoglycemia between the two groups(P ＞ 0.05).Conclusion For severe chest trauma patients with stress hyperglycemia,intensive insulin therapy can effectively improve the immunity,inhibit the inflammatory reaction,reduce the complication incidence,restore ventilation function and improve survival rate.

Insulin Therapy in Type 2 Diabetes Mellitus

@#Initiation of insulin therapy is challenging in the primary care setting without nursing support. Doctors have to prepare their practices to deal with these challenges in order not to delay insulin therapy when needed.

Effect of intensive insulin therapy on high mobility group box-1/nuclear factor-κB pathway in severe traumatic brain injury patient with stress hyperglycemia / 中华危重病急救医学

To explore the effect of intensive insulin therapy (IIT) on high mobility group box-1/nuclear factor-κB (HMGB1/NF-κB) signaling pathway in severe traumatic brain injury (sTBI) patient with stress hyperglycemia. Methods Sixty-one sTBI patients with stress hyperglycemia [Glasgow coma scale (GCS) ≤ 8, three times of random blood glucose levels > 11.1 mmoL/L, glycosylated hemoglobin (HbA1c) < 0.065] admitted to the Affiliated Huaian No.1 People's Hospital of Nanjing Medical University from July 2015 to October 2017 were enrolled. Patients were divided into IIT group (29 cases, keeping blood glucose at 4.4-7.8 mmol/L) and conventional glycemic therapy (CGT) group (32 cases, keeping blood glucose at 7.8-12.2 mmo/L) according to the random number table method. Before treatment and 1, 7 and 14 days after treatment, the levels of plasma HMGB1 and tumor necrosis factor-α (TNF-α) were measured by enzyme linked immunosorbent assay (ELISA); C-reactive protein (CRP) was determined by automatic biochemical analyzer, and NF-κB p65 gene expression in peripheral blood mononuclear cells was detected by real-time quantitative polymerase chain reaction (PCR). Results Nine patients were withdrawn from the observation because the 4 consecutive blood glucose monitoring did not reach the target value, combined with severe infection, or abandoned the treatment with serious brain damage. Finally, 52 patients were enrolled in the analysis, including 28 in CGT group and 24 in IIT group. The levels of plasma HMGB1, TNF-α, CRP and the expression of NF-κB gene in monocytes of the two groups at 1 day after treatment were significantly higher than those before treatment, and reached the peak value, then gradually decreased. After 7 days of treatment, they were significantly lower than 1 day. The levels of plasma CRP and TNF-α in the IIT group were significantly lower than those in the CGT group [CRP (mg/L): 36.7±4.4 vs. 45.1±6.1, TNF-α (ng/L): 42.4±9.7 vs. 53.2±9.1, both P < 0.05], the level of HMGB1 in plasma and the expression of NF-κB p65 in monocytes were significantly lower than those in the CGT group after 14 days of treatment [HMGB1 (μg/L): 60.1±8.7 vs. 80.5±9.1, NF-κB p65 (ΔCt): 35.8±8.5 vs. 53.5±7.3, both P < 0.05]. Conclusion IIT inhibits the inflammatory response in sTBI patients with stress hyperglycemia through HMGB1/NF-κB pathway.

The impact of exogenous glucocorticoids on glucose metabolism as evaluated by continuous glucose monitoring / 中华临床营养杂志

Glucocorticoids are widely used in clinical practice,and abnormal glucose metabolism due to the use of glucocorticoids is prevalent.There has been progress in studies evaluating post-glucocorticoid changes in blood glucose levels using continuous glucose monitoring.This paper reviews glycemic patterns and protocols for insulin treatment of abnormal glucose metabolism following the use of glucocorticoids as shown by continuous glucose monitoring.

Features of lipid ratios in patients with newly diagnosed T2DM and effects of intensive insulin treatment on them / 实用医学杂志

Objective To investigate the features of lipid ratios in patients with newly diagnosed T2DM, and the effects of intensive insulin treatment on them. Methods 90 patients with newly diagnosed T2DM and 58 matched people with normal glucose were enrolled to assess height,weight,waist circumference,blood glucose and lipid profiles. BMI,TC/HDL-C,TG/HDL-C,log(TG/HDL-C),LDL-C/HDL-C,HOMA-B and HOMA-IR were calculated respectively. All the patients received the continuous subcutaneous insulin infusion with insulin pump. The treatment continued for more 10~14 days after blood glucose reached the standard. All the above indi-cators were reexamined after treatment. Results Dyslipidemia in patients with newly diagnosed T2DM mainly showed as hypertriglyceridemia and decreased HDL-C compared to the control group(P<0.05). TC/HDL-C,TG/HDL-C,log(TG/HDL-C)and LDL-C/HDL-C significantly increased in these patients(P<0.01). After short-term intensive insulin therapy,all lipid ratios were significantly decreased and the changes of lipid ratios were positively correlated with the change of HOMA-IR(P<0.05). Conclusion Short-term intensive insulin therapy for patients with newly diagnosed type 2 diabetes can significantly lower the lipid ratios related to HDL-C. The effects may be closely related to improvement of insulin resistance.

Basal insulin combined with acarbose compared with premixed insulin treatment of type 2 diabetes efficacy and safety / 中国生化药物杂志

Objective To study the analysis of insulin glargine combined with acarbose in type 2 diabetes compared with pre mixed insulin treatment efficacy and safety. Methods 100 patients with type 2 diabetes mellitus treated in our hospital from March 2015 to August 2016 were selected and randomly divided into the control group and the experimental group, with 50 patients in each group. The control group were treated with premixed insulin treatment, the experimental group were treated with basal insulin combined with acarbose. The clinical indexes of the experimental group and the control group were compared and analyzed. Results After the corresponding treatment, the fasting blood glucose level of the control group was (7.56 ± 1.13) nmol / L, and the fasting blood glucose level of the experimental group was (7.01 ± 0.92) nmol / L. The level of fasting blood glucose in the experimental group was significantly lower than that in the control group, with statistical difference (P<0.05). The level of HbA1c in the experimental group was (7.01 ± 0.82)％, significantly lower than that in the control group, and the level of HbA1c (7.45 ± 0.91)％, with statistical difference (P<0.05). Among the 50 patients in the control group, hypoglycemia occurred in 20 patients, the incidence of hypoglycemia was 40％, significantly higher than that in the experimental group, and the incidence of hypoglycemia was 14％, which was statistically significant (P<0.05). Conclusion Basal insulin combined with acarbose compared with premixed insulin treatment of type 2 diabetes treatment can significantly hypoglycemic effect, high safety, with further clinical promotion and application significance.

Glycemic control and changes of inflammatory factors in severe sepsis patients and their clinical significance / 中华急诊医学杂志

Objective To investigate glycemic control,changes of inflammatory factors and their clinical significance in severe sepsis patients.Methods One hundred and three severe sepsis patients with abnormal hyperglycemia were randomly divided into the two groups and receive intensive insulin therapy (IIT) and conventional insulin therapy (CIT) respectively.According to glycosylated hemoglobin level,the two groups were further divided into stress hyperglycaemia and diabetes mellitus subgroups.The mortality and incidence of hypoglycemia were compared between the groups and subgroups.Enzyme linked immunosorbent assay was used to detect TNF-α,IL-6 levels before treatment,3 and 7 days after treatment.Results In IIT group,the mortality in diabetes mellitus subgroup was significantly higher than that in stress hyperglycaemia subgroup (66.7％ vs.30.8％,P ＜ 0.05),while the mortality in stress hyperglycaemia subgroup significantly higher than that in diabetes mellitus subgroup (54.1％ vs.25.0％,P ＜ 0.05) in CIT group.Multivariate Logistic regression analysis revealed IIT increased the risk for death in diabetes mellitus subgroup (OR =1.221,95％ CI:1.075-1.434),while decreased the risk for death in stress hyperglycaemia subgroup (OR =0.872,95％ CI:0.714-0.975).The incidence of hypoglycemia was significantly higher in IIT group than that in CIT group (13.7％ vs.1.9％,P ＜0.05).Before treatment,the levels of TNF-α,IL-6 in stress hyperglycaemia patients were significantly higher than those in diabetes mellitus patients.After 7 day treatment,The levels of TNF-α,IL-6 decreased significantly in stress hyperglycaemia patients (P ＜ 0.01),and decreased more significantly in IIT group than that in CIT group.Conclusion Severe sepsis patients with stress hyperglycaemia can attain better glycemia control and inhibition of inflammatory factors,and clinical benefit from IIT.

Influence of case management on short-term intensive insulin therapy effect in newly diagnosed type 2 diabetic patients in outpatient clinic / 中国糖尿病杂志

Objective To explore the influence of case management on short-term intensive insulin therapy effect,including treatment compliance,safety and glucose metabolic index in newly diagnosed type 2 diabetic patients in outpatient clinic. Methods A total of 100 newly diagnosed type 2 diabetic patients in outpatient clinic were enrolled in this study and randomly divided into 2 groups:intervention group (n=52)and control group (Con,n = 48 ). The intervention group received standard insulin injection case management provided by a team composed of doctors and nurse case manager. The control group received routine insulin injection education in outpatient. Attitudes and compliance of insulin treatment,incidence of hypoglycemia,fasting blood glucose (FBG) and glycated haemoglobin A1c (HbA1 c ) were compared between the two groups at baseline and after 3 months follow up. Results After intervention,the total score and scores by dimension of insulin treatment attitude were higher in intervention group than in Con group[(76.30 ± 4.06 )vs (60.53 ± 3.18 )score,P 0.05),although without statistical difference. FBG and HbA1 c were all lower in intervention group than in Con group [(6.79 ± 1.41 )vs (7.51±1.15)mmol/L,(6.62±0.69)％ vs (7.15±0.75)％,P <0.05]. Conclusion Case management could effectively improve the insulin treatment attitude and compliance,and then optimize glycemic control innewly diagnosed type 2 diabetic patients treated with short-term intensive insulin therapy in outpatient clinic.

Comparison of Antidiabetic Regimens in Patients with Type 2 Diabetes Uncontrolled by Combination Therapy of Sulfonylurea and Metformin: Results of the MOHAS Disease Registry in Korea

BACKGROUND: The aim of this study was to investigate the glucose-lowering efficacy of antidiabetic treatments in patients with type 2 diabetes mellitus (T2DM) uncontrolled by sulfonylurea plus metformin. METHODS: This open-label, multicenter, prospective, observational study was conducted in 144 centers in Korea, from June 2008 to July 2010, and included patients with T2DM who had received sulfonylurea and metformin for at least 3 months and had levels of glycosylated hemoglobin (HbA1c) >7.0% in the last month. Data of clinical and biochemical characteristics were collected at baseline and 6 months after treatment. The treatment option was decided at the physician's discretion. Subjects were classified into the following three groups: intensifying oral hypoglycemic agents (group A), adding basal insulin (group B), or starting intensified insulin therapy (group C). RESULTS: Of 2,995 patients enrolled, 2,901 patients were evaluated, and 504 (17.4%), 2,316 (79.8%), and 81 patients (2.8%) were classified into groups A, B, and C, respectively. Subjects in group C showed relatively higher baseline levels of HbA1c and longer duration of diabetes. The mean decrease in HbA1c level was higher in the insulin treated groups (−0.9%±1.3%, −1.6%±1.3%, and −2.4%±2.3% in groups A, B, and C, respectively, P=0.042). The proportion of patients who achieved target HbA1c <7.0% was comparable among the groups; however, intensified insulin therapy seemed to be the most effective in achieving the target HbA1c of 6.5%. CONCLUSION: These findings suggest that insulin-based therapy will be an important option in the improved management of Korean patients with T2DM whose glycemic control is not sufficient with sulfonylurea and metformin.